Tesamorelin ThGRF regulatory update

FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Feb. 24 to discuss an NDA from Theratechnologies for tesamorelin to treat excess abdominal fat in HIV-infected patients with li...